Ranitidine and the FDA Recall

In April 2020, the FDA announced that Zantac, or Ranitidine, will be recalled because of a probable carcinogen in the drug. There are many sources of the carcinogen, NDMA. The Ranitidine molecule itself can create it, but the risk is particularly high because this... read more